Assessing the Burden of Acinetobacter baumannii in Maryland: A statewide cross-sectional period prevalence survey

Infection Control and Hospital Epidemiology

Volumn 33, Issue 9, 2012, Pages 883-888

  Thom, Kerri A ^a   Maragakis, Lisa L ^b   Richards, Katie ^c   Kristie Johnson, J ^a   Roup, Brenda ^c   Lawson, Patricia ^c   Harris, Anthony D ^a   Fuss, Elizabeth P ^d   Pass, Margaret A ^e   Blythe, David ^c   Perencevich, Eli N ^f   Wilson, Lucy ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^d Carroll Hospital Center   (United States)

^e ST AGNES HOSPITAL   (United States)

^f UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TIGECYCLINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIAL LOAD; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BIOGEOGRAPHIC REGION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE SURVEILLANCE; EMERGENCY CARE; HEALTH CARE FACILITY; HIGH RISK PATIENT; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PREVALENCE; SAMPLE; SPUTUM CULTURE; UNITED STATES;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; COST OF ILLNESS; CROSS INFECTION; CROSS-SECTIONAL STUDIES; DRUG RESISTANCE, BACTERIAL; HEALTH CARE SURVEYS; HOSPITALS; HUMANS; MARYLAND; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; RESIDENTIAL FACILITIES; RESPIRATION, ARTIFICIAL;

EID: 84864956376     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/667376     Document Type: Article

References (19)

1. Sengstock DM, Thyagarajan R, Apalara J, Mira A, Chopra T, Kaye KS. Multidrug-resistant Acinetobacter baumannii: an emerging pathogen among older adults in community hospitals and nursing homes. Clin Infect Dis 2010;50(12):1611-1616.
2. Furuno JP, Hebden JN, Standiford HC, et al. Prevalence of methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii in a long-term acute care facility. Am J Infect Control 2008;36(7):468-471.
3. Gaynes R, Edwards JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41(6): 848-854.
4. Dent LL, Marshall DR, Pratap S, Hulette RB. Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis 2010;10:196.
5. Dizbay M, Tunccan OG, Sezer BE, Hizel K. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors. Scand J Infect Dis 2010;42(10):741-746.
6. Villegas MV, Hartstein AI. Acinetobacter outbreaks, 1977-2000. Infect Control Hosp Epidemiol 2003;24(4):284-295.
7. Wright MO. Multi-resistant gram-negative organisms in Maryland: a statewide survey of resistant Acinetobacter baumannii. Am J Infect Control 2005;33(7):419-421.
8. Maragakis LL, Tucker MG, Miller RG, Carroll KC, Perl TM. Incidence and prevalence of multidrug-resistant Acinetobacter using targeted active surveillance cultures. JAMA 2008;299(21): 2513-2514.
9. Pass MA, Kingsland BE, Weiger JM, Ross RW. The use of pulsedfield gel electrophoresis (PFGE) to characterize an outbreak of Acinetobacter baumannii/haemolyticus in Baltimore, Maryland. Presented at: Society for Healthcare Epidemiology of America, Fifth Decennial International Conference on Healthcare-Associated Infections; 2010; Atlanta.
10. Ajao AO, Robinson G, Lee MS, et al. Comparison of culture media for detection of Acinetobacter baumannii in surveillance cultures of critically-ill patients. Eur J Clin Microbiol Infect Dis 2011;30(11):1425-1430.
11. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 16th Informational Supplement. Wayne, PA: CLSI, 2006. CLSI document M100-S16.
12. Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrugresistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012;18(3): 268-281.
13. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33(9):2233-2239.
14. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32(8):470-485.
15. Denton M, Wilcox MH, Parnell P, et al. Role of environmental cleaning in controlling an outbreak of Acinetobacter baumannii on a neurosurgical intensive care unit. Intensive Crit Care Nurs 2005;21(2):94-98.
16. Simor AE, Lee M, Vearncombe M, et al. An outbreak due to multiresistant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management. Infect Control Hosp Epidemiol 2002;23(5):261-267.
17. Palmore TN, Michelin AV, Bordner M, et al. Use of adherence monitors as part of a team approach to control clonal spread of multidrug-resistant Acinetobacter baumannii in a research hospital. Infect Control Hosp Epidemiol 2011;32(12):1166-1172.
18. Marchaim D, Navon-Venezia S, Schwartz D, et al. Surveillance cultures and duration of carriage of multidrug-resistant Acinetobacter baumannii. J Clin Microbiol 2007;45(5):1551-1555.
19. Perencevich EN, McGregor JC, Shardell M, et al. Summer peaks in the incidences of gram-negative bacterial infection among hospitalized patients. Infect Control Hosp Epidemiol 2008;29(12): 1124-1131.